Click here to go to the previous page
Radiotherapy for Favorable Risk Prostate Cancer: A Review of all the Options
Program Code:
EDU206
Date:
Monday, September 22, 2008
SPEAKER(S):
Eric Horwitz, Chair, Fox Chase Cancer Center
W. Robert Lee, Professor, Duke University School of Medicine
LEARNER OUTCOMES:
-
Describe the expected efficacy and toxicity of external beam radiotherapy (3DCRT, IMRT and proton therapy) and brachytherapy (LDR and HDR) in men with favorable risk prostate cancer
-
Explain the importance of dose-volume constraints with external beam radiotherapy (3DCRT, IMRT and proton therapy) and brachytherapy (LDR and HDR)
-
Judiciously incorporate IGRT into practice